Triple-negative breast cancer: are we making headway at least?
about
MiRNAs and Other Epigenetic Changes as Biomarkers in Triple Negative Breast CancerThe fate of chemoresistance in triple negative breast cancer (TNBC)MicroRNA-223 Increases the Sensitivity of Triple-Negative Breast Cancer Stem Cells to TRAIL-Induced Apoptosis by Targeting HAX-1Cisplatin and gemcitabine as the first line therapy in metastatic triple negative breast cancer.Phytochemicals potently inhibit migration of metastatic breast cancer cellsExpression of RUNX1 correlates with poor patient prognosis in triple negative breast cancerCoordinate hyperactivation of Notch1 and Ras/MAPK pathways correlates with poor patient survival: novel therapeutic strategy for aggressive breast cancers.Targeting the SIN3A-PF1 interaction inhibits epithelial to mesenchymal transition and maintenance of a stem cell phenotype in triple negative breast cancer.miR-134 in extracellular vesicles reduces triple-negative breast cancer aggression and increases drug sensitivity.MiR-153 promotes breast cancer cell apoptosis by targeting HECTD3Non-benzoquinone geldanamycin analogs trigger various forms of death in human breast cancer cells.Glucocorticoid receptor antagonism as a novel therapy for triple-negative breast cancerPharmacological activation of FOXO3 suppresses triple-negative breast cancer in vitro and in vivoLong-term survival of advanced triple-negative breast cancers with a dose-intense cyclophosphamide/anthracycline neoadjuvant regimen.Activators of AMPK: not just for type II diabetes.Cancer stem cells and personalized cancer nanomedicine.Double gene siRNA knockdown of mutant p53 and TNF induces apoptosis in triple-negative breast cancer cells.Novel c-Met inhibitory olive secoiridoid semisynthetic analogs for the control of invasive breast cancerPost-nano strategies for drug delivery: Multistage porous silicon microvectors.Hedgehog signalling pathway orchestrates angiogenesis in triple-negative breast cancers.Prospective study of cyclophosphamide, thiotepa, carboplatin combined with adoptive DC-CIK followed by metronomic cyclophosphamide therapy as salvage treatment for triple negative metastatic breast cancers patients (aged <45).Targeting chaperonin containing TCP1 (CCT) as a molecular therapeutic for small cell lung cancer.HN1L Promotes Triple-Negative Breast Cancer Stem Cells through LEPR-STAT3 Pathway.Bioinformatics identification of dysregulated microRNAs in triple negative breast cancer based on microRNA expression profiling.miR-10b, miR-26a, miR-146a And miR-153 Expression in Triple Negative Vs Non Triple Negative Breast Cancer: Potential Biomarkers.MiR-145 promotes TNF-α-induced apoptosis by facilitating the formation of RIP1-FADDcaspase-8 complex in triple-negative breast cancer.Identification of miR-10b, miR-26a, miR-146a and miR-153 as potential triple-negative breast cancer biomarkers.Absence of AIF1L contributes to cell migration and a poor prognosis of breast cancer
P2860
Q26775086-0F28BB3E-B8A3-41B3-A19A-4F9566B0B94EQ26775232-61B0CE33-D165-4FED-88AC-29DC668606CFQ28554012-D100A7A4-E54F-4EF0-AB86-5513E0344264Q33415281-57CFE430-CB19-423B-A53E-D97140415275Q33810248-FCA6FC7B-4621-4E9D-9654-526933088E07Q33812500-55934508-3F47-4D2A-B307-21E770F28071Q34646291-687CF32C-EB1F-454D-8876-A2A3FF4D83EAQ36544024-054DBC4D-379D-41AB-AF5A-430B5F311914Q36544974-64BCE20E-CF15-4BD7-9693-1CA681026402Q37143959-E75F5945-EF70-4226-9CBD-F5DFFF88FF5EQ37278393-C305AC24-B33D-44B3-B3DF-498A72AF51F6Q37386056-47E6AB83-02A5-4DFD-8478-6BC45EC40379Q37520463-AEB492D2-1CB9-496F-9771-C8584DF3A376Q37650748-8789F83B-7291-46E7-A5F6-9B19901C2E10Q38243893-19A7418A-1ADF-41F1-B9C5-006E4EC8942DQ38702970-6571727D-894F-4C46-ABA7-F44F718C7B14Q38726515-C8F60755-D1B7-4B19-8F07-ED99B1806DF1Q38858554-97D6E74C-91CD-4BE8-9CC2-BA713CCB286DQ39410383-1C9B628A-EDCB-4980-94D1-B3537874EFFBQ41078110-E3396B9B-3F74-4CA3-83E7-D8600CB8E2D5Q41489984-00D53713-1316-4F16-86E6-3FA86952D00FQ47107751-6980BC02-EEF3-4F1E-8229-C3B0A3DD947FQ47295042-441A6A36-5266-4CEA-A6FD-91E1D89DA244Q49516769-343BAB69-8D1F-4B41-A0F7-5C795DE4E574Q51182190-D871DCF0-86B2-4FE5-91BC-D3A0AACB1781Q53219892-EE7936A9-4A0B-4491-B20A-00F6BDBC68ACQ54989577-4743DB08-E58C-4F2A-B2C6-3EE3BB71B865Q58762819-2BCE6A57-B1C5-4C0A-88E0-362F3D6BA1FB
P2860
Triple-negative breast cancer: are we making headway at least?
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Triple-negative breast cancer: are we making headway at least?
@ast
Triple-negative breast cancer: are we making headway at least?
@en
type
label
Triple-negative breast cancer: are we making headway at least?
@ast
Triple-negative breast cancer: are we making headway at least?
@en
prefLabel
Triple-negative breast cancer: are we making headway at least?
@ast
Triple-negative breast cancer: are we making headway at least?
@en
P2093
P2860
P356
P1476
Triple-negative breast cancer: are we making headway at least?
@en
P2093
Celine Bihan
Fabrice Andre
Monica Arnedos
Suzette Delaloge
P2860
P304
P356
10.1177/1758834012444711
P577
2012-07-01T00:00:00Z